ARMISTICE CAPITAL, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 148 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$58,664,640
-8.6%
4,612,000
+1.1%
0.90%
-3.2%
Q2 2023$64,204,800
+1.4%
4,560,000
+11.2%
0.93%
+1.9%
Q1 2023$63,345,000
-25.3%
4,100,000
-20.7%
0.91%
-38.3%
Q4 2022$84,769,080
-3.9%
5,172,000
+8.5%
1.48%
-3.3%
Q3 2022$88,208,000
+24.2%
4,768,000
-11.7%
1.53%
+23.5%
Q2 2022$71,010,000
+31.3%
5,400,000
-7.5%
1.24%
+18.5%
Q1 2022$54,100,000
+61.4%
5,836,000
+70.1%
1.05%
+90.9%
Q4 2021$33,513,000
+45.5%
3,430,154
+405.9%
0.55%
+40.5%
Q3 2021$23,038,000
+33.3%
678,000
+43.6%
0.39%
+26.2%
Q2 2021$17,280,000472,0000.31%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders